Bueno MU

No ORCID on file · 1 paper in corpus · active 2022
2022
Immunohematology ·doi:10.21307/immunohematology-2022-036

According to recent work group recommendations, individuals with the serologic weak D phenotypes should be RHD genotyped and individuals with molecular weak D types 1, 2, 3, 4.0, or 4.1 should be treated as D+. We report an African American…